- Quotes
- Dashboard
- Chart
- Historical Prices
- Options
- News & PR
- News
- Market Currents
- Press Releases
- Coverage
- Cramer
- Top Analysts
- Business Intelligence
- Transcripts
- Events
- Key Developments
- Earnings
- History & Projected
- Consensus
- Peer Earnings
- Filings
- SEC Filings
- Annual Report
- Financials
- Income Statement
- Balance Sheet
- Cash Flow
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
BAX Market Currents
more »
-
Friday 3:54 PM Baxter International (BAX -0.5%) says the results from two large, international multicenter trials it conducted show that a low glucose peritoneal dialysis regimen favorably impacted metabolic measures important for end-stage renal disease patients with diabetes, including blood glucose control and selected lipids. The combined results were presented at the 49th Annual European Renal Association - European Dialysis and Transplant Association congress in Paris.
Comment![Healthcare]
BAX in Focus
more »
BAX Related Articles
more »
BAX News
more »
-
at MarketWatch.com (Apr 19, 2012)
-
at CNBC.com (Mar 27, 2012)
-
at MarketWatch.com (Jan 26, 2012)
-
at CNBC.com (Jan 20, 2012)
-
at MarketWatch.com (Dec 14, 2011)
BAX Press Releases and Filings
more »
-
Business Wire (Fri, 3:41AM)
-
Business Wire (Wed, 4:15PM)
-
Business Wire (May 16, 2012)
-
Business Wire (May 7, 2012)
-
Business Wire (May 2, 2012)
BAX Latest Transcript
more »
BAX Cramer
more »
-
Wed, Mar 28
-
Tue, Aug 16, 2011
-
Thu, May 27, 2010
BAX Instablog posts
more »
BAX vs. ETF Alternatives
Company Description
Baxter develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma and other chronic and acute medical conditions. As a global, diversified healthcare company, Baxter applies a unique... More